Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Telehealth Billing and Coding Considerations

Oct 16, 2020/Article

What you need to know about documentation, coding, and billing consideration when providing telehealth services.

Medicare Denials, Audits, and Appeals

Denials happen. So do successful appeals.

Every Student Succeeds Act (ESSA)

Jun 1, 2017/Article

APTA is committed to preserving the provisions of Individuals with Disabilities in Education Act to ensure that students with disabilities have access to physical therapy services necessary to take full advantage of a free and public education.

Billing for Your Services

Feb 3, 2020/Article

Gain an understanding of various billing processes and options for billing for your services.

Get Ready for the 30th Annual National Physical Therapy Month

Sep 6, 2022/Article

It’s time to plan your celebration of the profession — and the important role you play in it.

Cannabis Use and Physical Therapy

Oct 1, 2022/Article

As more states legalize cannabis for both medicinal and recreational use, the chances are increasing that PTs and PTAs will treat patients who use it.

Final 2023 Medicare Physician Fee Schedule: What You Need to Know, Part 1

Nov 3, 2022/Article

Payment is the focus of this installment: Cuts, therapy thresholds, updated calculations that could be good for PTs, and more.

Final 2023 Medicare Physician Fee Schedule: What You Need to Know, Part 3

Nov 8, 2022/Article

In our final installment: MIPS, quality measures, MIPS Value Pathways, and more.

Prior Authorization Comment Letters From APTA Members, Part 1

Feb 22, 2023/Article

We're sharing real-world examples of what makes for a great comment letter. This installment: a pediatric PT's perspective.

Advocacy in Action: Prior Authorization Comment Letters from Members, Part 3

Mar 6, 2023/Article

We're sharing real-world examples of what makes for a great comment letter. This installment: an APTA payment chair's perspective.